Archimydes

Building and scaling the world's most ambitious startups. Nearly 5% of the US population suffers from a cardiac arrhythmia. Current solutions are entirely inadequate to effectively monitor and triage this population. Archimydes is helping AccurKardia build solutions that change this narrative.